Tag Archive | "PPMI in the News"

Alzforum Profiles the PPMI Expansion

Alzforum featured PPMI in an article highlighting a presentation given by PPMI?s Principal Investigator, Kenneth Marek, at the Keystone Symposia Parkinson?s Disease: Genetics, Mechanisms, and Therapeutics Conference held March 2-7 in Colorado.

Continue reading...

Michael J. Fox Foundation Press Release Announces PPMI Genetic Cohort

Continue reading...

PPMI focus on hyposmia featured in Neurology Now

Neurology Now, the magazine for patients and caregivers published by the American Academy of Neurology, featured an article profiling Michael J. Fox and the importance of participating in research. The PPMI prodromal cohort and the recruitment of individuals with hyposmia was highlighted as an exciting way for readers to get involved. In addition to providing a link to the Smell Survey, the article describes some of the science behind the link between hyposmia and Parkinson's Disease.

Continue reading...

PPMI Prodromal Profiled in UK Financial Times

Financial Times, a UK-based newspaper, recently profiled PPMI site Imperial College London (ICL) and the recruitment of hyposmic individuals. The article focuses on the link between olfactory dysfunction and Parkinson's disease, and gives a recap of the efforts the PPMI team at ICL have done attempting to recruit for this new prodromal cohort.

Continue reading...

PPMI Profiled in ‘Practical Neurology’

A summary of the Parkinson's Progression Markers Initiative (PPMI) was recently published in Practical Neurology. The article gives a detailed account of the history and rationale of the study, as well as an overview of the study protocol. The newly added Prodromal and Genetic cohorts are also described in detail, as well as the potential overlap with the Alzheimer's Disease Neuroimaging Initiative (ADNI).

Continue reading...

NY Stem Cell Foundation partners with PPMI

Last week, The New York Stem Cell Foundation (NYSCF) Research Institute announced in a press release that they will partner with PPMI to generate stem cell lines from PPMI participants. The stem cell lines will used to understand the etiology and progression of the disease as compared to the existing and future biomarker data in the PPMI database.

Continue reading...

PPMI Site PI interviewed on NECN Morning Show

Dr. Samuel Frank, PPMI Site PI at Boston University, made a recent appearance on the New England Cable News (NECN) Morning Show to talk about the PPMI Prodromal Cohort. Dr. Frank discussed the link between hyposmia and PD, and the rationale behind adding a this new cohort.

Continue reading...

Op-Ed in Scientific American by MJFF CEO Todd Sherer highlights PPMI

This week, Scientific American published an Op-Ed by Todd Sherer, PhD, Chief Executive Office of The Michael J Fox Foundation for Parkinson's Research. The op-ed is a call to action for researchers to continue investigating the promising leads already discovered, and to expand the existing strategies in PD research through collaboration. Dr. Sherer highlights the recent PPMI results published in JAMA Neurology as a "critical milestone in pursuit of biomarkers that could lead to swifter diagnosis and drug development"

Continue reading...

Prodromal recruitment featured in Boston University news

The Boston University Medical Center (BUMC) news blog released an article this week focusing on the PPMI Prodromal Cohort. Dr. Sam Frank, PPMI Site PI at BUMC, explained the importance of this new cohort - "Understanding risk factors for Parkinson's disease could help to identify therapies that may prevent the onset of motor symptoms in future generations of PD". The article also directs readers to the Smell Survey on the MJFF website.

Continue reading...

MJFF CEO Todd Sherer discusses PPMI in Medscape interview

Todd Sherer, PhD, Chief Executive Office of The Michael J Fox Foundation for Parkinson's Research, was recently interviewed by Medscape about PPMI and other promising PD research. Dr. Sherer discusses the goal of PPMI, as well as the recent publication in JAMA Neurology using PPMI data that gives evidence of proteins in the CSF levels of which were lower in people with early PD compared with age- and gender-matched controls.

Continue reading...